| GIORGIO PISANI | PRIME PEOPLE
area is the prerogative of only those innovative companies offering safe and effective solutions. Solutions that IBSA has obtained after the experience gained in the field of dermatology, with products dedicated to wound healing and tissue regeneration. The dermoaesthetic product
formulations offered are based on the Hydrolift® Action concept, the innovative and exclusive therapeutic approach, aimed at preventing and treating the physiological reduction of hyaluronic acid in the skin, encouraging restoration of its functionality as well as hydration, elasticity, and tone. An approach which amply supports the concept of 'curing wrinkles' compared with the typically cosmetic 'wrinkle filling' concept. Hydrolift® Action is an expression of
the synergic action of the bio- regenerative and mechanical lifting of skin depression by HA, thanks to the combined use of hyaluronic acid, both natural and modified. The primary role of this
complementary action is fundamentally that of 'wrinkle care' and is carried out by natural hyaluronic acid which guarantees, in addition to efficacy and natural results, a high safety profile for both the patient and the doctor. Our products, all designed, developed,
and manufactured in our factories, are products that we believe in and not just the latest trend created with the only goal to generate profit. This is IBSA’s philosophy and this is the way we plan on remaining in this market. It’s possible that our strategy may not bring immediate results, but we are confident that we will reach our goals in the very near future.
Could you give us more details on your new product PROFHILO®? IBSA’s patented technology of stabilised hybrid complexes of hyaluronic acid has enabled us to create a product, dedicated to dermal bioremodeling, containing 64 mg of natural, non-cross-linked HA in a 2 ml syringe, while maintaining the manageability to inject with a 29 G needle. The product’s unique rheological properties result in a new device for the physician to counteract skin laxity of the middle third of the face. PROFHILO® has revealed encouraging
preliminary clinical results. In addition to a reduced inflammatory response,
years. Resources essential to understand the overall demands from the market, to the users of the products, or the doctors, to those of patients.
What you are currently researching in the aesthetic field? The knowledge and experience that has been accumulated after years of research regarding hyaluronic acid, has allowed us to continuously improve our products VISCODERM® and ALIAXIN®, which are currently present in the market. Thanks to a patented technology, we
are able to select and optimise specific hyaluronic acid with different molecular weights to treat specific areas of the body and to obtain clinically predictive and effective results. In addition to hyaluronic acid, we are
PROFHILO® has a proven duration eight times greater than that of high molecular weight HA alone. In the field of biorejuvenation
procedures, PROFHILO® is an innovative product that delivers outstanding results from the first session, with a high patient compliance due to the minimally invasive technique. The product is in fact designed to be
administered with a very simple technique specifically created to minimise the risks while maximising the diffusion of the product. The protocol consists of only two sessions with a 1 month interval, to be repeated twice a year. The technique was studied in our
laboratories and further developed by a team of doctors and surgeons with whom we have collaborated with for
prime-journal.com | March 2015
studying new substances that can complement and enhance the action of this important molecule. Substances that, in the future, may play a potentially important role as hyaluronic acid in recent decades. Our commitment will always be
focused on the study of safe products, not necessarily all having a purely aesthetic purpose, but that favour a profound improvement, treating various skin problems. It is precisely through following this
philosophy that our research is aimed at obtaining products with high aesthetic performance while maintaining a low or zero content of chemical agents that modify the molecular structure.
❚
75
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96